Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Ipsen Biopharmaceuticals (Not applicable)
- License Information
-
More Information
Article History
Received: 17 February 2019
Accepted: 27 January 2020
First Online: 7 February 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AF is an employee of PharmaLex Sweden, which received consulting fees from Ipsen. LR is employed by Ipsen. PE has received educational grants from Ipsen and Allergan and Medtronic.
